Erratum: Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; Results of a randomised phase II study (DaVINCI) and meta-analysis (European Journal of Cancer (2011) 47:12 (1826-1836))

SJ Clarke; S Yip; C Brown; GA Van Hazel; DT Ransom; D Goldstein; G Mark Jeffrey; NC Tebbutt; M Buck; RM Lowenthal; A Boland; V Gebski; J Zalcberg; R John Simes

Journal article

Erratum: Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; Results of a randomised phase II study (DaVINCI) and meta-analysis (European Journal of Cancer (2011) 47:12 (1826-1836))

SJ Clarke, S Yip, C Brown, GA Van Hazel, DT Ransom, D Goldstein, G Mark Jeffrey, NC Tebbutt, M Buck, RM Lowenthal, A Boland, V Gebski, J Zalcberg, R John Simes

European Journal of Cancer | ELSEVIER SCI LTD | Published : 2012

DOI: 10.1016/j.ejca.2011.12.001

University of Melbourne Researchers

Niall Tebbutt Author

Keywords

Life Sciences & Biomedicine

3211 Oncology and Carcinogenesis

32 Biomedical and Clinical Sciences

Clinical Trials and Supportive Activities

Women'S Health